Advertisement

Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact

Panagiotis Baliakas, Sabine Jeromin, Michalis Iskas, Anna Puiggros, Karla Plevova, Florence Nguyen-Khac, Zadie Davis, Gian Matteo Rigolin, Andrea Visentin, Aliki Xochelli, Julio Delgado, Fanny Baran-Marszak, Evangelia Stalika, Pau Abrisqueta, Kristina Durechova, George Papaioannou, Virginie Eclache, Maria Dimou, Theodoros Iliakis, Rosa Collado, Michael Doubek, M. Jose Calasanz, Neus Ruiz-Xiville, Carolina Moreno, Marie Jarosova, Alexander C. Leeksma, Panayiotis Panayiotidis, Helena Podgornik, Florence Cymbalista, Achilles Anagnostopoulos, Livio Trentin, Niki Stavroyianni, Fred Davi, Paolo Ghia, Arnon P. Kater, Antonio Cuneo, Sarka Pospisilova, Blanca Espinet, Anastasia Athanasiadou, David Oscier, Claudia Haferlach and Kostas Stamatopoulos on behalf of ERIC, the European Research Initiative on CLL

Article Information

Citation 
vol. 133 no. 11 1205-1216
PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted September 2, 2018
  • Accepted December 18, 2018
  • Published online March 14, 2019.

Article Versions


Contributors 
  • Panagiotis Baliakas, 1Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden;
  • Sabine Jeromin, 2MLL Munich Leukemia Laboratory, Munich, Germany;
  • Michalis Iskas, 3Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece;
  • Anna Puiggros, 4Laboratori de Citogenètica Molecular, Servei de Patologia, Hospital del Mar, Barcelona, Spain; 5Grup de Recerca Translacional en Neoplàsies Hematològiques, Programa de Recerca en Càncer, Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Barcelona, Spain;
  • Karla Plevova, 6Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic; 7Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic;
  • Florence Nguyen-Khac, 8Hematology Department and Sorbonne University, Hopital Pitie-Salpetriere, INSERM U1138, Paris, France;
  • Zadie Davis, 9Department of Haematology, Royal Bournemouth Hospital, Bournemouth, United Kingdom;
  • Gian Matteo Rigolin, 10Hematology Section, St. Anna University Hospital, Ferrara, Italy;
  • Andrea Visentin, 11Hematology Division, Department of Medicine, University of Padua, Padua, Italy;
  • Aliki Xochelli, 12Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece;
  • Julio Delgado, 13Department of Hematology, Hospital Clínic, Institut d’Investigacions Biomèdiques August Pi i Sunyer, Universitat de Barcelona, Barcelona, Spain;
  • Fanny Baran-Marszak, 14Laboratoire d’hématologie, Hopital Avicenne, Assistance Publique–Hôpitaux de Paris, Paris, France;
  • Evangelia Stalika, 12Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece;
  • Pau Abrisqueta, 15Servei d’Hematología, Hospital Vall d'Hebron, Barcelona, Spain;
  • Kristina Durechova, 7Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic;
  • George Papaioannou, 3Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece;
  • Virginie Eclache, 14Laboratoire d’hématologie, Hopital Avicenne, Assistance Publique–Hôpitaux de Paris, Paris, France;
  • Maria Dimou, 16Hematology Section, First Department of Propedeutic Internal Medicine, National and Kapodistrian University of Athens, Laikon University Hospital, Athens, Greece;
  • Theodoros Iliakis, 16Hematology Section, First Department of Propedeutic Internal Medicine, National and Kapodistrian University of Athens, Laikon University Hospital, Athens, Greece;
  • Rosa Collado, 17Servicio de Hematología, Consorcio Hospital General Universitario, Valencia, Spain;
  • Michael Doubek, 6Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic; 7Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic;
  • M. Jose Calasanz, 18Servicio de Genética Citogenética, Departamento de Genética, Universidad de Navarra, Pamplona, Spain;
  • Neus Ruiz-Xiville, 19Servei Laboratori Hematologia, ICO-Hospital Germans Trias i Pujol, Institut de Recerca Contra la Leucèmia Josep Carreras (IJC), Universitat Autònoma de Barcelona, Badalona, Spain;
  • Carolina Moreno, 20Servei d’Hematologia, Hospital Universitari de la Santa Creu i Sant Pau, Barcelona, Spain;
  • Marie Jarosova, 6Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic; 7Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic;
  • Alexander C. Leeksma, 21Department of Hematology and Lymphoma and Myeloma Center Amsterdam, Academic Medical Center Amsterdam, University of Amsterdam, Amsterdam, The Netherlands; 22Department of Experimental Immunology, Cancer Center Amsterdam and Infection and Immunity Institute of Amsterdam, Amsterdam, The Netherlands;
  • Panayiotis Panayiotidis, 16Hematology Section, First Department of Propedeutic Internal Medicine, National and Kapodistrian University of Athens, Laikon University Hospital, Athens, Greece;
  • Helena Podgornik, 23Department of Hematology, University Medical Centre Ljubljana, Ljubljana, Slovenia; and
  • Florence Cymbalista, 14Laboratoire d’hématologie, Hopital Avicenne, Assistance Publique–Hôpitaux de Paris, Paris, France;
  • Achilles Anagnostopoulos, 3Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece;
  • Livio Trentin, 11Hematology Division, Department of Medicine, University of Padua, Padua, Italy;
  • Niki Stavroyianni, 3Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece;
  • Fred Davi, 8Hematology Department and Sorbonne University, Hopital Pitie-Salpetriere, INSERM U1138, Paris, France;
  • Paolo Ghia, 24Strategic Research Program in CLL, Division of Experimental Oncology, IRCCS San Raffaele Scientific Institute and Università Vita-Salute San Raffaele, Milan, Italy
  • Arnon P. Kater, 21Department of Hematology and Lymphoma and Myeloma Center Amsterdam, Academic Medical Center Amsterdam, University of Amsterdam, Amsterdam, The Netherlands; 22Department of Experimental Immunology, Cancer Center Amsterdam and Infection and Immunity Institute of Amsterdam, Amsterdam, The Netherlands;
  • Antonio Cuneo, 10Hematology Section, St. Anna University Hospital, Ferrara, Italy;
  • Sarka Pospisilova, 6Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic; 7Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic;
  • Blanca Espinet, 4Laboratori de Citogenètica Molecular, Servei de Patologia, Hospital del Mar, Barcelona, Spain; 5Grup de Recerca Translacional en Neoplàsies Hematològiques, Programa de Recerca en Càncer, Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Barcelona, Spain;
  • Anastasia Athanasiadou, 3Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece;
  • David Oscier, 9Department of Haematology, Royal Bournemouth Hospital, Bournemouth, United Kingdom;
  • Claudia Haferlach, 2MLL Munich Leukemia Laboratory, Munich, Germany;
  • Kostas Stamatopoulos, 1Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden; 12Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece;

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output